Health News
Gerresheimer Starts the Year Successfully in 2008
04:23 Apr 14, 2008
Gerresheimer Starts the Year Successfully in 2008
04:23 Apr 14, 2008
The rating agency Standard & Poor's has raised the Gerresheimer Group's rating from BB to BB+ with "Outlook stable". This means that Gerresheimer is now only one step away from an investment grade rating.
04:03 Apr 14, 2008
The rating agency Standard & Poor's has raised the Gerresheimer Group's rating from BB to BB+ with "Outlook stable". This means that Gerresheimer is now only one step away from an investment grade rating.
04:03 Apr 14, 2008
EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of preclinical and mechanism of action data for its selective kinase inhibitor, ENMD-
04:03 Apr 14, 2008
Isis Pharmaceuticals, Inc. announced additional results from its ongoing Phase 2 open-label extension study of mipomersen in patients with familial hypercholesterolemia . In FH patients exposed to mipomersen for as long as 16 months, the safety profile o
04:03 Apr 14, 2008
A new member-based organization, Practice Greenhealth, has named Robert N. Jarboe as its Executive Director. Practice Greenhealth reflects the combined experience of three powerful initiatives to improve the environmental performance of the healthcare se
04:03 Apr 14, 2008
The Larry King Cardiac Foundation is proud to announce that the St. Jude Medical Foundation is once again the presenting sponsor for its annual fundraising gala. Celebrating the Foundation's 20th anniversary, An Evening with Larry King and Friends will b
04:01 Apr 14, 2008
Kosan Biosciences Incorporated today announced that the Phase 2 trial of epothilone KOS-1584 in patients with non-small cell lung cancer has been initiated. The Phase 2 trial is an open-label, multi-center, monotherapy study of KOS-1584 in patients with
03:03 Apr 14, 2008
BioMed Realty Trust, Inc. today announced the signing of a new lease at the Pacific Research Center inNewark, California. Revance Therapeutics, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative biopha
02:03 Apr 14, 2008
Obesity expert and author Dr. Sanford Siegal, best known as the creator of the popular Dr. Siegal's COOKIE DIET weight loss system and hunger controlling foods, today announced that he has posted on the www.CookieDiet.com web site a new entry in his pers
02:03 Apr 14, 2008
BiPar Sciences, Inc. today announced positive preclinical data demonstrating the activity of its lead poly ADP-ribose polymerase inhibitor, BSI-201, in ovarian cancer models. The results highlight the anti-tumor activity of BSI-201 through PARP activity
02:03 Apr 14, 2008
Get ready to feel good. That's the mantra for Northwest songwriter Dean Backholm. He certainly has every reason to feel good these days. The national March of Dimes announced it has selected his single "Mother and Child" for a debut fundraiser
02:03 Apr 14, 2008
Istithmar World Capital and ESPA International have joined forces in which IWC has acquired a 40% equity stake in ESPA.
00:13 Apr 14, 2008
Epigenomics AG , a molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic tests for cancer, updates on its program for the development of test for prostate cancer screening and diagnosis. The company presen
23:42 Apr 13, 2008
19894 - 19908 of 32275 Stories
<<
<
Next 15 Health News
>
>>
Search News
Daily News
